Edwards LifesciencesEW

NYSE · USA · Segment 7 of 8 in the Medicine, pharma & life science value chain: Medtech & devices

Heart valves, delivered by catheter as with TAVR or implanted surgically.

Medtech & devices: Medical equipment and devices, from surgery and cardiology to robotics.

Key metrics

Market cap

$53.8B

Price

$90.50

Today

+0.8%

Return YTD

+5.3%

Return 1Y

+10.6%

P/E

53.5

P/S

8.3

P/B

5.1

Data as of 2026-08-25 · updates daily after U.S. close

Theme exposure

MedtechStructural heartHeart valves

In the value chain

Products & services

Transcatheter heart valves (TAVR)
Surgical valves
Structural heart

Competitors

Risks

Competition in TAVR
Growth slowdown

Same segment: Medtech & devices

Intuitive SurgicalISRG StrykerSYK MedtronicMDT Boston ScientificBSX Becton DickinsonBDX GE HealthCareGEHC ResMedRMD Zimmer BiometZBH

Compare EW

EW vs ISRG EW vs SYK EW vs MDT EW vs BSX EW vs BDX EW vs GEHC

See where Edwards Lifesciences sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →